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Background: Coarctation is a congenital heart defect with an incidence of 5–8%, more
frequent in boys; however, the overwhelming majority of patients undergo surgery earlier
as pediatric patients. Currently, the treatment of choice in adolescents and adults is
endovascular management.
Method: We used all three common catheter-based techniques: simple balloon dilatation,
stent placement, and stent-graft placement. All treated patients underwent pre- and post-
procedural CT angiography.
Group of patients: Between 2004 and 2014, we treated a total of 10 patients with coarctation.
They included seven men and three women, with a mean age of 41.1 (21–59) years. Eight
patients were treated for native coarctation, and two for re-coarctation. Dominant features
included hypertension (eight patients) and left-sided heart failure (four patients); some
patients presented with multiple conditions at a time. Simple dilatation was performed in
two patients while four had both stent and stent-graft placement.
Results: All procedures were technically successful, with a long-term beneﬁcial effect seen in
all patients. All patients with hypertension showed improvement, with medication either
reduced or completely discontinued in four cases.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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.Introduction
The term, coarctation, refers to a narrowing of the aortic
isthmus or, in rare cases, of the thoracic or abdominal aorta. It
is a local ridge bulging from the posterior and lateral aortic
walls toward the ductal oriﬁce, and formed by thickened
media or, possibly, intima. Coarctation occurs in 5 to 8% of
congenital heart defects, more commonly in boys than in girls,
at a ratio of 2–5:1 [1–3]. Its exact cause is unknown. Coarctation* Corresponding author . Tel.: +420 261362670.   
E-mail address: jino@ikem.cz (J. Novotný).
http://dx.doi.org/10.1016/j.crvasa.2015.03.008
0010-8650/# 2015 The Czech Society of Cardiology. Published by Elseshould be distinguished from tubular hypoplasia, the latter
being a narrowing of the proximal segment of the aortic arch to
60%, distal aorta to 50%, and aortic isthmus to 40%. Unlike
coarctation, tubular hypoplasia is characterized by a normal
wall structure. Critical aortic narrowing in infants and
neonates is associated with completely different hemody-
namic and clinical presentations, compared with coarctation
in older children and adolescents. Neonates require urgent
treatment, which is predominantly surgical given the long-termvier Sp. z o.o. All rights reserved.. 
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 1 8 1 – e 1 8 6e182failure rate of balloon dilatation [4]. The currently preferred
technique used in adolescents and adults is endovascular
treatment, particularly in those with re-coarctation. Our paper
presents our experience with this technique.
Materials and methods
All our patients underwent pre-procedural CT angiography
and anatomical ﬁndings were used to decide on the size of
material and technique employed. All patients underwent
scheduled, non-urgent procedures.
We used the three standard techniques for catheter-based
management: simple balloon dilatation, balloon dilatation
with stent placement, and stent-graft placement with addi-
tional balloon dilatation. In each case, the decision on the
particular technique to be used was made based on the
following criteria: (a) simple dilatation with stenoses of
borderline signiﬁcance, anatomically unsuitable for stent
placement; (b) stent placement with signiﬁcant stenoses
localized close to arch branches, and in younger patients; (c)
stent-graft placement with tight stenoses, older patients, and
post-stenotic dilatation. All procedures for endovascular
management began with catheterization, an uncomplicated
task with less signiﬁcant stenosis. A challenging problem was
trying to pass through the very tight stenoses and post-
stenotic dilatation. In this case, we had to use a pre-shaped
catheter and to manoeuver a steerable guide-wire within the
dilated aorta, which can be difﬁcult, given the small slit
provides poor support for the catheter.
The therapeutic strategy changed over the 10-year period,
with more sophisticated instruments being used. While
simple dilatation was commonly used in the early endovas-
cular era, the currently preferred technique is stent or stent-
graft implantation. As the original stents required the use of
thick 18–20 F sheaths, actual placement was performed from
the femoral artery – similar to stent grafts – using a cut-down
approach. Previously, we used custom-made, steel, self-
expandable stents made by ELLA, a Czech manufacturer based
in Hradec Králové. At present, we use nitinol, laser-cut, self-
expandable Sinus-XL stents (OptiMed, Ettlingen, Germany)
adapted for 0.035-inch sheaths. The stent size ranged from 28
to 36 mm in diameter, and 40 to 60 mm in length; given the
availability of 10 F sheaths, there was no need for groin cut-
down. The procedures were performed exclusively under local
anesthesia, with bleeding after sheath removal stopped by
compression using a Femostop system (OptiMed, Ettlingen,
Germany). The same approach was adopted with balloon
dilatation using 7 F sheaths for balloon catheters measuring
14 mm in diameter. The type of anesthesia used with stent
grafts and stents requiring inguinal cut-down was at the
anesthesiologist's discretion, depending on whether epidural
anesthesia or general anesthesia was performed. Given the
pain associated with dilatation, particularly with tight native
stenoses, patients received analgesics (opiates) during the
procedure, after which administration continued for as many
as several days post-procedurally. Heparin was only adminis-
tered in patients who developed pelvic artery obstruction that
resulted in blood ﬂow reduction due to the thick sheath
systems. The stent grafts used in our center were eitherValiant (Medtronic, Santa Rosa, CA, USA) or Relay (Bolton
Medical, Inc., Sunrise, FL, USA), invariably using the shortest
lengths available (100 mm), as all the lesions were short. Both
products are identical in design (endograft) featuring a nitinol
skeleton on a woven fabric (Dacron). All stent grafts were
tubular and of the same width at their proximal and distal
ends. The stent-graft diameter was invariably chosen in order
to be 20% larger than the diameter of the aorta at its anchoring
site.
When opting for simple balloon dilatation, the technique
was similar to that employed in percutaneous transluminal
angioplasty. Caution had to be exercised in keeping the
necessary dilatation pressure in the balloon, since the large-
diameter balloon catheters are more prone to rupture. Even
tight stenoses were successfully dilated at pressures of 4–
6 atm.
When using a stent, dilatation was ﬁrst undertaken with a
smaller-diameter (usually 10–12 mm) balloon, followed by
stent placement. The stent diameter was about 10% larger
than that of the aorta. The dilatation was subsequently
performed using a larger balloon, measuring up to 24 mm in
diameter and invariably 20–30% smaller than the diameter of
the intact aorta.
The third option for endovascular treatment was stent-
graft placement via the femoral artery. Again, the ﬁrst step was
to dilate the tight aortic stenosis with a smaller (10–12 mm)
balloon catheter, with the partly dilated stenosis subsequently
covered with the fabric component of the stent graft. When
necessary, the left subclavian artery was covered, either
completely (in patients with a patent right vertebral artery and
developed circle of Willis) or partly, to make sure brain
perfusion would not be impaired. Prior to opening the stent
graft, systolic blood pressure was decreased to a level below
100 mmHg to avoid possible stent-graft migration due to blood
ﬂow. Next, the stenosis site was dilated using a balloon
catheter, again 20–30% smaller than the diameter of the intact
aorta.
Prior to and after the procedure, we performed a direct
measurement to determine the pressure gradient, ﬁrstly as a
conﬁrmation of indication of the procedure, and secondly as
the main indicator of technically successful coarctation
management. The minimum level of the systolic pressure
gradient for the endovascular procedure was 20 mmHg. The
measurement was most often made by withdrawal of a pigtail
catheter with the values measured above and under stenosis.
Less often, pressure was measured with the tip of the catheter
above the stenosis in the aortic arch, with the second pressure
value obtained from the sheath with the distal end in the iliac
artery. Pre-procedurally, the pressure gradients ranged be-
tween 20 and 100 mmHg, with the highest post-procedural
gradient being 12 mmHg. Our deﬁnition of technical success
was absence of narrowing of the stent graft (non-signiﬁcant at
most) in the form of residual stenosis or recoil and decrease in
the systolic pressure gradient at less than 15 mmHg.
Clinical success was deﬁned as more readily controlled
hypertension (reduction of antihypertensive medication or
non-pharmacological normalization of blood pressure), ab-
sence of claudication or prolongation of the claudication
interval, and remission of signs of left-sided heart failure. Post-
procedural follow-up included CT assessment. The ﬁrst
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procedure, with subsequent examinations at a 1-year interval
in ﬁrst patients. After gaining some experience with the
procedure and mainly due to the absence of any complications
leading to new interventions, we changed our strategy to
perform CT FU within the ﬁrst 3 months only. The examinationFig. 1 – (a) CT angiogram of the thoracic aorta with coarctation; (
catheter-based dilatation; (d) follow-up angiography with a stent
CT 4 days post-procedurally with an insignificant residual steno
normalized findings.always included CT angiography with reconstructions asses-
sing stenosis signiﬁcance, and stent and stent-graft integrity.
Also assessed were the size and number of collateral arteries.
Further CT imaging would have been indicated only if there
had been any clinical symptoms present, leading to suspicion
of restenosis or other late complications.b) angiographic findings prior to dilatation; (c) balloon
 graft placed at the site of original coarctation; (e) follow-up
sis; (f) another CTA assessment at 8 months – completely
Table 1 – Group of patients. Number of patients, lesion type, reason for management, and technique used.
Patient M/F Coarctacion Re-coarctation Hypertension Cardiac failure Pseudoaneurysm Claudication Balloon Stent Stent graft
1M 1 0 1 1 0 0 1 0 0
2M 1 0 0 1 0 0 1 0 0
3M 1 0 1 0 0 0 0 1 0
4M 1 0 1 1 0 0 0 0 1
5M 0 1 0 0 1 0 0 0 1
6F 1 0 1 0 0 0 0 1 0
7M 1 0 1 0 0 0 0 0 1
8M 1 0 1 0 0 1 0 0 1
9F 1 0 1 0 0 0 0 1 0
10F 0 1 1 1 0 0 0 1 0
Total 8 2 8 4 1 1 2 4 4
Table 2 – Outcomes and complications of coarctation
management.
Technical success 10
Periprocedural death 0
Rupture/aneurysm/dissection 0/0/1
Embolism/vascular complications 0/0
Stroke 0
Groin complications 0
Table 3 – Follow-up CT after treatment.
Restenoses
Signiﬁcant 1
Insigniﬁcant 2
None 7
Wall/mural lesions
Aneurysm 0
Dissection 1
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A total of 10 patients were treated in our center between 2004
and 2014. They included seven men and three women with a
mean age of 41.1 (age range, 21–59) years. Eight patients had
primary treatment of native coarctation, and two underwent
re-coarctation treatment. All procedures were elective. All
cases of native coarctation were incident ﬁndings, while, in the
two cases of re-coarctation, the patients were lost to follow-up
after surgery in childhood. Simple dilatation was performed in
two patients, and four patients underwent both stent and
stent-graft implantation (Fig. 1). An anesthesiologist was
available for all procedures requiring groin cut-down, which
applied for four stent-graft placements and two stent place-
ments. Four procedures were undertaken under local anes-
thesia. Prior to endovascular treatment, all patients were
assessed by a cardiologist, which revealed clinical symptoms
of hemodynamically signiﬁcant stenosis conﬁrmed by CT
angiography. The reasons for treatment are summarized in
Table 1, the most frequent being hypertension in eight cases,
followed by left-sided heart failure. One patient with re-
coarctation and a postoperative pseudoaneurysm was found
to have a small sac without mural thrombosis. Another patient
experienced claudications after several hundred meters,
which posed a major limitation in his case, as he was a young
athlete.
Results
The procedure was technically successful in all our patients,
with stents and stent grafts implanted in sites as necessary
and dilatation balloons expanded as required. There were no
fatal intra-procedural complications (Table 2) and no peri-
procedural deaths. A short, approximately 3 cm long dissec-
tion at the site of dilatation, distally from the stenosis, was
noted in one case of simple balloon dilatation; the dissection
was left untreated. The origin of the left subclavian artery was
covered with a stent graft in two cases, neither of which
required revascularization of the covered artery.
At present, the mean follow-up period is 4.1 years. All
patients have had follow-up assessment by a cardiologist
and at least one has undergone follow-up CT angiography. Along-term beneﬁcial therapeutic effect has been seen in all 10
patients. There was one death 3 years post-procedurally not
related to coarctation management. The procedure has never
been repeated, nor has surgery been required. All eight
hypertensive patients showed improvement, with reduced
doses of antihypertensive drugs and antihypertensive therapy
completely discontinued in four cases. One patient was treated
with simple dilatation, while having signiﬁcant re-coarctation
documented on a follow-up CT angiogram, also showed
clinical improvement and thus did not require aggressive
management. The other CT-angio ﬁndings are summarized in
Table 3. Claudications resolved in one patient and a pseudoa-
neurysm in another had been covered by a stent graft and are
considered as treated. Follow-up examinations have not
documented any changes in the short dissection, which
developed during dilatation. Long-term ﬁndings in patients
with stent or stent-graft placement remain unchanged, with
no signs of impaired stent or stent-graft integrity.
Discussion
The therapeutic strategy in our center has evolved in parallel
with the development of materials available for endovascular
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we used was simple balloon dilatation, which, while consid-
ered safe and effective in the management of native coarcta-
tion of the aorta, is associated with a signiﬁcant incidence of
re-coarctation. Therefore, we decided to experiment by
indicating a less tight stenosis for balloon angioplasty. Repeat
dilatation was possible [4] and consequently, both patients
managed by simple balloon dilatation did not show ideal
ﬁndings on follow-up CT assessments, one developing a
signiﬁcant re-stenosis and the other, a short dissection.
Although consensus has not been reached on whether or
not this is an appropriate technique (surgery vs. balloon
angioplasty) for native aortic coarctation, it is generally
accepted that endovascular access is the method of choice
for re-coarctation [4–7]. In the following period, the evolution
of custom-made stents allowed us to extend our indications to
a very tight stenosis. The ﬁrst ever stent-based management of
coarctation of the aorta was undertaken in early 1990. Stent
placement helps decrease the incidence of acute elastic recoil
and late re-stenosis [1]. Most recently, we have begun to
employ stent grafts and commercially available stents. Use of
stent grafts is recommended for the treatment of coarctation,
in particular when combined with the following conditions:
patent ductus arteriosus, Takayasu arteritis, very tight steno-
ses, aneurysms, marked tortuosity of the aorta, and cases
associated with a high risk of aneurysm formation or
development of dissection. In our center, stent grafts were
used in patients with very tight stenoses. While we have not
yet had a single patient with complete aortic atresia, there
have been reports of coarctation resulting in a completely
severed aorta, although producing a good outcome when using
a stent graft [8]. As a preventive measure to manage potential
rupture, it is our policy to always have a stent graft at hand
even when we are planning to place a stent only. The technicalFig. 2 – (a) Huge collateral circulation at the coarctation in the ba
following successful coarctation dilatation/stenting (CT angiograsuccess rate in all of our patients having stent or stent-graft
implantation is comparable with data reported by other
authors; the long-term beneﬁcial effect is also consistently
good. Unlike other reports, quite surprisingly, native coarcta-
tion was more frequent than re-coarctation in our patient
group [9–12]. Overall, the patient sets published to date have
been small, despite being reported by large center reports
[13,14].
Use of modern stents with suture systems and low-proﬁle
sheaths to manage an unprepared groin when using a stent
graft allows the procedure to be performed under local
anesthesia, where the role of the anesthesiologist is conﬁned
to analgosedation. An issue yet to be addressed is further
management of patients, particularly the insertion of a
central venous catheter (mostly not used). Central venous
access is critical in order to make up for blood loss
management, should a rupture occur. While rare, aortic
rupture is a fatal complication; however, only four cases have
been reported to date [15]. As anesthesiologists are able to
better relieve chest tenderness associated with dilatation, we
consider their presence a deﬁnite advantage. While the risk of
intra-procedural complications is substantially reduced by
detailed knowledge of surgical procedures performed in
childhood, the unavailability of patients' medical records
poses a major problem.
No clear-cut recommendations regarding follow-up of
patients with coarctation, especially follow-up using imaging
techniques, have yet been published. Computer-tomography-
based follow-up at a 5-year interval has been suggested [16,17].
Computer tomography-based follow-up of most of our
patients with stent or stent-graft implantation showed either
complete normalization of the aortic diameter or only an
insigniﬁcant residual stenosis, with diminished collateral
circulation (Fig. 2).ck; (b) reduced blood flow through the collateral vessel bed
m).
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placement has revealed no major changes. None of the
patients have experienced undesirable events, such as rupture
or re-coarctation. Although given the risk of dissection this
subgroup of patients should be preferably followed up by CT in
the early postprocedural period only, CT-based follow-up will
not provide any further new information. Based on the
radiation exposure in young patients on long-term follow-
up, it is our recommendation to perform CT assessment only
in cases where there is a change in the clinical ﬁndings.
Patients undergoing simple balloon dilatation should prefera-
bly have annual CT follow-up given their higher risk of a re-
stenosis, aneurysm formation, or dissection [1].
Conclusion
As also conﬁrmed by our results, endovascular treatment of
coarctation is a safe and rapid technique posing only a little
burden to the patient. Another advantage is the short
hospitalization time. In our center, surgical treatment is
reserved only for cases of complex anatomies that are not
suitable for catheterization.
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